Morio A, Ujike H, Nomura A, Tanaka Y, Morita Y, Otani K, Kishimoto M, Harano M, Inada T, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Ann N Y Acad Sci. 2006 Aug;1074:411-7. doi: 10.1196/annals.1369.041.
Cocaine- and amphetamine-regulated transcript (CART) was originally discovered as a peptide that increased in the rat striatum after injection of a psychostimulant drug, such as cocaine or amphetamine, and is suggested to play potential roles in drug dependence. We tested the genetic association between the CART gene and methamphetamine (METH) dependence and/or psychosis. The subjects were 203 patients with METH dependence and 239 age- and gender-matched healthy controls. Two single nucleotide polymorphisms (SNPs) of the CART gene, -156A>G and IVS1 + 224G>A, were examined . There were no significant differences in genotype and allele distributions of the polymorphisms between patients with METH dependence and/or psychosis and controls. Neither were significant differences in subgroups of clinical phenotypes, for example, age at first consumption of METH, latency to onset of psychotic symptoms after the first consumption of METH, prognosis of psychosis after therapy, complication of spontaneous relapse to a psychotic state, or multisubstance abuse status, observed. The present findings suggest that the CART gene may not play a pivotal role in the development of METH dependence and psychosis, at least in a Japanese population.
可卡因和苯丙胺调节转录肽(CART)最初被发现是一种在注射可卡因或苯丙胺等精神兴奋药物后大鼠纹状体中含量增加的肽,并且被认为在药物依赖中发挥潜在作用。我们测试了CART基因与甲基苯丙胺(METH)依赖和/或精神病之间的遗传关联。研究对象为203例METH依赖患者和239名年龄及性别匹配的健康对照者。检测了CART基因的两个单核苷酸多态性(SNP),即-156A>G和IVS1 + 224G>A。在METH依赖和/或精神病患者与对照者之间,这些多态性的基因型和等位基因分布没有显著差异。在临床表型亚组中也未观察到显著差异,例如首次使用METH的年龄、首次使用METH后出现精神病症状的潜伏期、治疗后精神病的预后、自发复发至精神病状态的并发症或多物质滥用状况。目前的研究结果表明,至少在日本人群中,CART基因可能在METH依赖和精神病的发生发展中不发挥关键作用。